$SOFI

Keough Kelli sold $203K of SOFI

Keough Kelli (EVP, GBUL, SIPS) sold 11,286 shares of SoFi Technologies, Inc. (SOFI) at $18.00 ($0.20M total) on 2026-08-20 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Keough Kelli
Published Aug 24, 2026, 10:26 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 24, 2026, 10:59 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SOFI
Neutral
high confidence
Mentioned
$SOFI
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SOFINeutralLow
01

Why it matters

The transaction represents a routine liquidity event for the insider with limited market impact.

02

Market read

Small insider sale; unlikely to affect SoFi's stock price.

03

What to watch

Potential future sales under the 10b5‑1 plan.

Relevance 3/10Novelty 4/10Timing: filing date 2026-08-20 (post‑market)

Background

SEC Form 4 filing discloses insider transactions; used by traders to gauge insider sentiment.

Company-level read

Ticker impact

$SOFINeutralHigh confidence
Context

EVP Kelli Keough sold 11,286 shares of SoFi for $203,184 via a 10b5‑1 plan on 2026‑08‑20.

Expected impact

No significant price impact expected.

Evidence & confidence

Sale size is modest relative to total holdings and market cap; insider remains a large holder.

Market effects

None

None

None

Counterpoint

Sale could signal insider confidence issues, but size is too small to matter.

Key entities

  • SoFi Technologies, Inc.

    US‑listed fintech platform (ticker SOFI).

  • Kelli Keough

    Executive Vice President, GBUL, SIPS at SoFi.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TMDXMed

2 Stocks Down 28% and 34% to Buy and Hold

TransMedics Group (TMDX) and SoFi Technologies (SOFI) have seen significant stock declines. TMDX's revenue grew 21% YoY to $189.9M, but profits fell 52%. SOFI's revenue rose 43% to $1.2B, with net income up 61%. Both face near-term challenges but are seen as long-term opportunities.

$CFFNMed

Citizens sues SoFi as fights over talent, pipelines persist

Citizens Bank has sued SoFi Bank for allegedly poaching loan officers and pipelines, claiming it violated confidentiality agreements and caused operational harm. Citizens accuses SoFi of a 'nationwide campaign' that led to $5 million in lost revenue in Connecticut. The lawsuit seeks injunctive relief to prevent SoFi from using alleged stolen information. SoFi reported $1.4 billion in mortgage originations in Q2 2024, according to its earnings.

$SOFIMed

Where Will SoFi Stock Be in 5 Years?

SoFi Technologies (SOFI) shares are down 31% YTD despite strong revenue growth. Analysts are mixed, with 10 rating it a buy, 14 a hold, and 5 a sell. Piper Sandler's $22 price target cites cross-selling success and a young, credit-worthy customer base. The company reported $1.2B in Q1 revenue, up 40% YoY, and raised full-year guidance to $4.75B-$4.85B, but kept earnings guidance unchanged.